Cargando…

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review

BACKGROUND: The histopathological changes of Alzheimer's disease (AD) are detectable decades prior to its clinical expression. However, there is a need for an early, inexpensive, noninvasive diagnostic biomarker to detect specific Alzheimer pathology. Recently developed neuroimaging biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gleerup, Helena Sophia, Hasselbalch, Steen Gregers, Simonsen, Anja Hviid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525835/ https://www.ncbi.nlm.nih.gov/pubmed/31191751 http://dx.doi.org/10.1155/2019/4761054

Ejemplares similares

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer’s Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time
por: Musaeus, Christian Sandøe, et al.
Publicado: (2023)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives
por: Jensen, Camilla Steen, et al.
Publicado: (2015)

The Added Value of Cerebrospinal Fluid Neurofilament Light Chain to Existing Diagnostic Methods and Biomarkers in a Mixed Memory Clinic Cohort of Consecutive Patients
por: Gleerup, Helena Sophia, et al.
Publicado: (2022)

Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease
por: Gjerum, Le, et al.
Publicado: (2021)

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting
por: Schjønning Nielsen, Malene, et al.
Publicado: (2016)

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
por: Jensen, Camilla Steen, et al.
Publicado: (2017)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2023)

Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
por: Schjønning Nielsen, Malene, et al.
Publicado: (2018)

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease
por: Jensen, Camilla Steen, et al.
Publicado: (2020)

Resting State EEG in Exercise Intervention Studies: A Systematic Review of Effects and Methods
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Effects of aerobic exercise on event-related potentials related to cognitive performance: a systematic review
por: Gusatovic, Julia, et al.
Publicado: (2022)

Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson
por: Wolgin, Michael, et al.
Publicado: (2022)

Evaluating 2-[(18)F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
por: Gjerum, Le, et al.
Publicado: (2020)

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer’s disease and mild cognitive impairment
por: Poulsen, Keld, et al.
Publicado: (2014)

Cost-effectiveness of a randomised trial of physical activity in Alzheimer’s disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark
por: Sopina, Elizaveta, et al.
Publicado: (2017)

Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
por: Oernbo, Eva Kjer, et al.
Publicado: (2022)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Saliva as a biomarker for dental caries: A systematic review
por: Hegde, Mithra N., et al.
Publicado: (2019)

A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease
por: Hinge, Christian, et al.
Publicado: (2022)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
por: Cui, Yangyang, et al.
Publicado: (2022)

Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
por: Knorr, Ulla, et al.
Publicado: (2019)

Saliva: A diagnostic biomarker of periodontal diseases
por: Patil, Priti Basgauda, et al.
Publicado: (2011)

Protein Biomarkers of Periodontitis in Saliva
por: Taylor, John J.
Publicado: (2014)

Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases
por: Basilicata, Michele, et al.
Publicado: (2023)

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
por: Bermejo-Pareja, Felix, et al.
Publicado: (2010)

Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Agarwal, Deevyankar, et al.
Publicado: (2021)

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022)

Biomarkers in Alzheimer's Disease: A Review
por: Chintamaneni, Meena, et al.
Publicado: (2012)

A Review on Saliva-Based Health Diagnostics: Biomarker Selection and Future Directions
por: Kumari, Swati, et al.
Publicado: (2023)

The Roles of Biomarkers of Oxidative Stress and Antioxidant in Alzheimer's Disease: A Systematic Review
por: Chang, Ya-Ting, et al.
Publicado: (2014)

Saliva: a challenging human fluid to diagnose brain disorders with a focus on Alzheimer’s disease
por: Zürcher, Christine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_03cbi7p999seu9g0n1ub8larrj